Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Raabe

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Vaccine|February 1, 2023
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)Vanessa Raabe, Lilin Lai, Juliet Morales, et al.
Lancet (London, England)|July 14, 2020
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19Sheila Shaigany, Marlis Gnirke, Allison Guttmann, et al.
Frontiers in Microbiology|October 19, 2020
The Immune Response to Eastern Equine Encephalitis Virus Acquired Through Organ TransplantationVanessa Raabe, Lilin Lai, Yong Xu, et al.
Open Forum Infectious Diseases|November 2, 2020
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized PatientsRobert J Ulrich, Andrea B Troxel, Ellie Carmody, et al.
Open Forum Infectious Diseases|January 31, 2019
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole BloodHana M El Sahly, Rodion Gorchakov, Lilin Lai, et al.
The Journal of Infectious Diseases|February 9, 2022
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model InoculumNadine Rouphael, Allison Beck, Amy E Kirby, et al.
Nature|August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Nature|January 20, 2021
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
The New England Journal of Medicine|October 14, 2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy StudyEdward E Walsh, Robert Frenck, Ann R Falsey, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Vaccine|February 1, 2023
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)Vanessa Raabe, Lilin Lai, Juliet Morales, et al.
Lancet (London, England)|July 14, 2020
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19Sheila Shaigany, Marlis Gnirke, Allison Guttmann, et al.
Frontiers in Microbiology|October 19, 2020
The Immune Response to Eastern Equine Encephalitis Virus Acquired Through Organ TransplantationVanessa Raabe, Lilin Lai, Yong Xu, et al.
Open Forum Infectious Diseases|November 2, 2020
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized PatientsRobert J Ulrich, Andrea B Troxel, Ellie Carmody, et al.
Open Forum Infectious Diseases|January 31, 2019
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole BloodHana M El Sahly, Rodion Gorchakov, Lilin Lai, et al.
The Journal of Infectious Diseases|February 9, 2022
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model InoculumNadine Rouphael, Allison Beck, Amy E Kirby, et al.
Nature|August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Nature|January 20, 2021
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
The New England Journal of Medicine|October 14, 2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy StudyEdward E Walsh, Robert Frenck, Ann R Falsey, et al.
Pageof 3